This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2004
Title: Richard Allsopp: Innovator in Telomerase Research
Introduction
Richard Allsopp is a notable inventor based in Mountain View, California, recognized for his contributions to the field of biotechnology. With a particular focus on understanding cellular processes related to aging, he has secured a patent that showcases the potential applications of his work in addressing age-related diseases.
Latest Patents
Richard Allsopp holds one patent for his invention titled "Mouse telomerase reverse transcriptase." This groundbreaking invention provides for urine telomerase reverse transcriptase (mTERT) enzyme proteins and nucleic acids. It also includes methods for isolating and expressing these nucleic acids and proteins. The implications of this patent are significant, as it relates to the control of cell proliferation and aging, with potential applications in combating age-related diseases such as cancer.
Career Highlights
Throughout his career, Richard has dedicated his research efforts to the intricate mechanisms of telomerase and its effects on cellular health and longevity. His work is instrumental in advancing our understanding of how cellular aging can be managed, contributing to the broader field of regenerative medicine and therapeutics aimed at treating diseases prevalent in older populations.
Collaborations
In addition to his own research, Richard has collaborated with esteemed colleagues including Gregg B Morin and Ronald A DePinho. These partnerships foster a collaborative environment that enhances innovation and drives forward the research initiatives focusing on biotechnology and aging.
Conclusion
Richard Allsopp's innovative research and patent for mouse telomerase reverse transcriptase mark a significant step forward in understanding aging and its associated diseases. His ongoing work, along with collaborations with other experts in the field, continues to pave the way for potential breakthroughs in the realm of biotechnology, highlighting the importance of innovation in addressing some of today's most pressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile